GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160 | -71.6% | 42,319 | -67.7% | 0.01% | -75.0% |
Q1 2023 | $564 | +66.4% | 131,146 | +52.2% | 0.06% | +33.3% |
Q4 2022 | $339 | -99.9% | 86,154 | +3.9% | 0.04% | -27.6% |
Q3 2022 | $440,000 | +263.6% | 82,946 | +349.4% | 0.06% | +222.2% |
Q2 2022 | $121,000 | -4.0% | 18,457 | +4.0% | 0.02% | +12.5% |
Q4 2021 | $126,000 | – | 17,739 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |